Neonatal cholestasis is a condition that affects infants, typically within the first few months of life. It is characterized by a blockage of bile flow from the liver, which leads to a buildup of bile acids in the blood. Bile is a yellow-green fluid that is produced by the liver and stored in the gallbladder. It plays a crucial role in the digestion and absorption of fats in the intestines.
When there is a blockage in the bile ducts, bile cannot flow properly from the liver to the intestines. This results in a buildup of bile acids in the blood, which can lead to a variety of symptoms and complications. Neonatal cholestasis can be caused by a variety of factors, including infections, genetic disorders, metabolic disorders, and structural abnormalities in the bile ducts.
The ICD-10 code for neonatal cholestasis is P78.81, which is used by healthcare providers to classify and code this condition for billing and administrative purposes. Diagnosis of neonatal cholestasis typically involves a physical examination, blood tests to measure levels of bile acids and other liver function tests, imaging studies such as ultrasound or MRI, and sometimes a liver biopsy to determine the underlying cause of the blockage.
Symptoms of neonatal cholestasis can vary depending on the underlying cause and severity of the blockage. Common symptoms include jaundice, which is a yellowing of the skin and eyes due to the buildup of bilirubin in the blood, pale stools, dark urine, poor weight gain, irritability, and itching. In severe cases, neonatal cholestasis can lead to liver damage, failure to thrive, and even death if left untreated.
Treatment for neonatal cholestasis aims to relieve the blockage of bile flow, manage symptoms, and prevent complications. This may involve medications to improve bile flow, nutritional support to promote growth and development, and in some cases, surgical intervention to remove the blockage or repair structural abnormalities in the bile ducts. It is important for infants with neonatal cholestasis to be closely monitored by a healthcare provider to ensure proper management of the condition.
In conclusion, neonatal cholestasis is a serious condition that requires prompt diagnosis and treatment to prevent long-term complications. The ICD-10 code for neonatal cholestasis is P78.81, which is used to classify and code this condition for healthcare billing and administrative purposes. If you suspect that your infant may have neonatal cholestasis, it is important to seek medical attention promptly to ensure proper evaluation and management of the condition.
